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FAD-modified human glutathione reductases were reconstituted from apoenzyme using the FAD analogues 
6-SH-FAD, 6-SCN-FAD, 6-OH-FAD, 6-NH2-FAD and 8-OH-FAD. The catalytic activities of the modified 
enzymes were substantially lower than for the native enzyme. All five species could be crystallized, but only those 
containing 6-SH-FAD, 6-OH-FAD and 6-NH2-FAD yielded crystals that could be analyzed. X-ray analyses and 
structural refinements were performed at 0.27 nm and 0.30 nm resolution resulting in R factors around 13.5%. 
The crystal structures showed the additional non-hydrogen atoms and small conformational changes of the 
polypeptide that were obviously induced by the substituents of the FAD analogues. The observed changes together 
with spectroscopic and activity data permit some conclusions about the chemical nature of the substituents. 
The flavoenzyme glutathione reductase catalyzes the re- 
duction of oxidized glutathione at the expense of NADPH. 
The human enzyme is a homodimer of two 52.4-kDa subunits 
with one FAD/subunit. It is structurally and functionally well 
known [l -31; its crystal structure has been established at 
0.154 nm resolution [4]. Numerous substrate- and ligand- 
binding studies were performed in order to elucidate enzyme 
catalysis by correlating structural with kinetic data [5  - 71. 
Recently, these experiments were supplemented by site-direct- 
ed mutations of the glutathione reductase species from 
Escherichia coli [8]. 
For studying flavin-polypeptide interactions, FAD ana- 
logues carrying modifications at the isoalloxazine ring have 
been used as substitutes for native FAD [9]. Human 
glutathione reductase is a particularly good model system for 
such experiments, because its structure is precisely known and 
its apoenzyme is reasonably stable and binds various FAD 
analogues. Some FAD-modified glutathione reductases have 
already been studied with respect to their spectroscopic and 
catalytic properties [lo - 121. Here, we analyze FAD-modified 
glutathione reductases by X-ray diffraction and attempt to 
correlate structural with spectroscopic and catalytic data. 
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Abbreviations. GR(6-SH-FAD), the FAD-modified enzyme 
glutathione reductase from human erythrocytes as reconstituted from 
the apoenzyme and 6-SH-FAD (the same nomenclature is used for 
the other FAD analogues); F,,,od,obrr observed structure factor ampli- 
tudes for crystalline glutathione reductase reconstituted with FAD 
analogues; F60H,obr, FsSH, obs and FsNHZ,  oba indicate particular modifi- 
cations; Fn,t,obs, observed structure factor amplitudes for the native 
enzyme; M,,,, talc, calculated structure factor phases for the native 
enzyme. 
Enzyme. NADPH : glutathione oxidoreductase (EC 1.6.4.2). 
MATERIALS AND METHODS 
In our experiments we used the FAD analogues 6-SH- 
[15] and 8-OH-FAD [16] all of which are specified in Fig. 1. 
Glutathione reductase was isolated from human erythrocytes 
as described by Krohne-Ehrich et al. [17]. The apoenzyme 
was obtained by saturating a holoenzyme solution with 
(NH4)2S04 at 4°C and pH 3.0 [18]. This leads to precipitation 
and release of FAD. The precipitate was washed several times. 
Because of the extreme pH conditions this procedure was 
finished as fast as possible, usually within 90 min. The FAD- 
free precipitate was dissolved and stored in 100 mM Tris/ 
HCl, 10 mM EDTA, pH 8.7, at concentrations of 4-7 mg 
apoenzyme/ml. The protein concentrations were determined 
photometrically using A280 = 1.0 as the absorption coef- 
ficient for 1 mg apoenzyme/ml [19]. 
The enzyme was reconstituted by adding a slight excess 
of the respective FAD analogue to the apoenzyme. After 
incubating for 1 h at room temperature to allow complete 
binding of the FAD analogue, the solution of the reconstituted 
enzyme was centrifuged using an Amicon Centricon 10 
ultrafilter to remove excess FAD analogue and low-molecular- 
FAD [13], 6-SCN-FAD [13], 6-OH-FAD [14], 6-NH2-FAD 
FAD : X = H ,  Y = C H ,  F 
I ln  I 
I ( I ~  ’ y ~ N ~ y o  6-SH-FAD : X = SH, Y = CH3 
6-SCN-FAD: X = SCN, Y = CH, 
yH 6-OH-FAD : X = OH, Y = CH-, 4 0  HnC N’ 4 
5 6-NH2-FAD: X = NHZ, Y = CH3 
8-OH-FAD : X = H, Y = OH 
c; I x 
Fig. 1. Isoalloxazine moiety of FAD showing the modified positions. 
For all FAD analogues R is ribityl-5’-ADP, as in native FAD 
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mass contaminants. In the same manner, the buffer was 
changed and the enzyme was concentrated for crystallization. 
The spectral studies were performed in storage buffer con- 
sisting of 100 mM potassium phosphate, 200 mM KCl, 1 mM 
EDTA, 14 mM mercaptoethanol, pH 7.0. For 6-SCN-FAD 
we used the same procedures, but avoided mercaptoethanol 
throughout. The enzyme activity was measured under stan- 
dard conditions [17] in 100 mM potassium phosphate, 
200 mM KCl, 1 mM EDTA, 0.5 mg/ml bovine serum albu- 
min, pH 6.9, at 25 "C. 
The reconstituted FAD-modified enzymes were crys- 
tallized at 20 "C using the hanging-drop method under the 
same conditions employed previously for the native enzyme 
[20]. The drop consisted of 0.8 M (NH4)$04, 0.1 M potas- 
sium phosphate, pH 7.0, with a protein concentration of 
about 16 mg/ml. The reservoir was filled with 1 ml 1.2 M 
(NH4),S04, 0.1 M potassium phosphate, pH 7.0. Crystalliza- 
tion was also achieved (often with better results) without the 
buffer. The crystals could be stored for months in 1.5 M 
(NH4),S04, 0.1 M potassium phosphate, pH 7.0. The same 
buffer was used for the X-ray analyses. 
X-ray data were collected on a modified four-circle dif- 
fractometer [21] and processed to obtain the structure factor 
amplitudes Fmod, obs. Taking the observed structure factor am- 
plitudes Fn,t,obs and the calculated phases anat, ca,c of the native 
enzyme from [4], a (Fmod,obs - Fna,,obs) . expia,,t,.al, difference- 
Fourier map was calculated that showed the structural 
changes caused by the modifications of FAD. Electron densi- 
ties and models were visualized on a graphics system (model 
PS330, Evans & Sutherland, USA) using the program 
FRODO [22]. For structural refinement of the 6-SH-FAD- 
modified enzyme [GR(6-SH-FAD)] we used program TNT 
[23]. When the more convenient program XPLOR [24] became 
available, it was applied for refining the 6-OH-FAD- and 
6-NHz-FAD-modified glutathione reductases, GR(6-OH- 
FAD) and GR(6-NH2-FAD), respectively. 
RESULTS 
Spectral and catalytic properties 
The FAD-modified glutathione reductases can be charac- 
terized by their absorption spectra [12, 14-16, 25, 261. The 
measured A,, values of the main absorption bands of the 
bound FAD analogues are given in Table 1. On binding to the 
apo form of the enzyme, the A,, values of the FAD analogues 
increased, usually in the order of 10 nm. However, no A,,, 
shift occurred with 6-OH-FAD. 
The analogue 6-SH-FAD can be deprotonated at the sub- 
stituent S6a (i.e. sulfur bound to C6, see Fig. 1). On dis- 
sociation, an electron pair of S6a conjugates with the 
isoalloxazine nucleus giving rise to an absorption band around 
650 nm. Using this absorption band, the pK value of 6-SH- 
FAD has been determined as 5.9 in the free state [13], and as 
< 5.0 when bound to glutathione reductase 1111. The electronic 
and spectral properties of 6-OH-FAD are similar to those of 
6-SH-FAD; it has a similar band around 650nm. The pK 
value of 6-OH-FAD has been determined as 7.1 in the free 
state [lo, 141. We have now measured a pK of 5.6 -t 0.5 for 
the bound analogue in GR(6-OH-FAD). Given these pK 
values, the enzyme-bound 6-OH-FAD and 6-SH-FAD ana- 
logues are predominantly in their anionic state at the pH 7.0 
of the X-ray analyses. 
The increased acidic nature of enzyme-bound 6-SH-FAD 
and 6-OH-FAD as compared to the free state must result from 
Table 1. Spectral and catalytic properties of glutathione reductase re- 
constituted with FAD analogues 
All data were obtained at pH 7.0 in the buffers given in the text. The 
catalytic activity is defined as [(specific activity of FAD-modified 
enzyme) ~ (specific activity of apoenzyme)]/(specific activity of native 
enzyme). The error for the 6-substituted FAD analogues is i 1 % and 
that for 8-OH-FAD is 2 %  relative catalytic activity, indicating that 
GR(8-OH-FAD) could be inactive. The larger error for 8-OH-FAD 
relates to the lower binding affinity of this analogue 
Enzyme-bound FAD A,, of main Relative catalytic 















a stabilization of the anionic charge within the protein. In 
6-SH-FAD and 6-OH-FAD the negative charge is partially 
located at the substituent atoms S6a and 06a and partially in 
the isoalloxazine nucleus, where it is enhanced in the region 
around N l  and 02a. A partial negative charge at 06n and 
S6a is stabilized by the contacting positively charged amino 
group of Lys66. A partial negative charge around N1 and 02a 
is stabilized by the favorably oriented amide dipoles of the 
a-helix of amino acid residues 339-354 that contacts 02a 
For 6-NH2-FAD in the free state, no spectral changes, 
and thus no ionization, occur in the physiological pH range. 
There are two measurable pK values, the first one around 1 
where N6a accepts a proton, and the second one around 10 
where N3 loses a proton [28]. The pK for the deprotonation 
of the 6-NH2 group is greater than 13 [28]. As a consequence, 
the 6-NHz substituent has no formal charge at pH 7.0 of the 
X-ray analysis. Since the lone electron pair of N6a conjugates 
with the isoalloxazine, nucleus, however, N6n carries a partial 
positive charge. 
The catalytic activities of the modified glutathione re- 
ductases are also given in Table 1. All of them are appreciably 
lower than the activity of the native enzyme. Due to the error 
margins, the activities of GR(6-SCN-FAD) and GR(6-OH- 
FAD) could be as high as 1% of that of the native enzyme 
and the activity of GR(8-OH-FAD) could be essentially zero. 
~ 7 1 .  
Structural studies 
Crystallography. Crystals could be obtained from human 
glutathione reductase reconstituted with all five FAD ana- 
logues. Crystals suitable for X-ray diffraction, however, grew 
only from GR(6-SH-FAD), GR(6-OH-FAD) and GR(6- 
NH,-FAD). The enzymes GR(6-SCN-FAD) and GR(8-OH- 
FAD) could only be crystallized up to sizes of 250 
x 150 x 70 pm3 and 200 x 100 x 100 pm3, respectively, which 
are too small for reasonable data collection on a dif- 
fractometer. The crystallization of GR(8-OH-FAD) was com- 
plicated by the weak binding of this analogue to the 
apoenzyme, which may have given rise to inhomogeneous 
protein ensembles. The relatively low binding constant of 8- 
OH-FAD as compared to FAD was discovered when 8-OH- 
FAD was slowly washed out on concentrating GR(8-OH- 
FAD) in the Centricon tube. 
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All three analyzed FAD-modified human glutathione re- 
ductases crystallized in space group B2 and are isomorphous 
with the native enzyme crystals (Table 2). Data were collected 
up to 0.27 nm resolution. The structural refinements con- 
verged at R factors around 13.5% with good geometries 
(Table 2). The quality of the structure analyses is also demon- 
strated in the maxima of the difference-Fourier maps of GR(6- 
SH-FAD) and GR(6-OH-FAD). These maxima are at the S6a 
and 06a  positions, and their heights (Table 2) correlate well 
with the number of electrons of sulfur and oxygen. At the 
given resolution and the achieved good R factors, the general 
accuracy of the atomic coordinates can be expected to be 
0.03 nm. 
In the native enzyme there is a cavity around the C6 atom 
of isoalloxazine [4]. This hole extends over a distance of about 
0.5 nm in the direction of the C6-S6a, C6-06a and C6-N6a 
bonds of the modified flavins. Given this free space, the incor- 
poration of the additional 6-SH, 6-OH and 6-NHz groups 
caused only small conformational changes of the polypeptide. 
For the most part, these changes occurred at residues Gly62, 
Cys63, Lys66 and Glu201, which surround the substituents at 
C6. It should be noted that the environment of the C6 atom 
is polar, which in conjunction with the available space explains 
the high binding constants of FAD analogues that carry a 
small polar group at C6. Since the obtained resolutions of the 
X-ray analyses are merely 0.27 nm and 0.30 nm, the quantifi- 
cation of these shifts is limited by the residual error. 
The structure of GR(6-SH-FAD). The highest peak in the 
difference-Fourier map between GR(6-SH-FAD) and native 
glutathione reductase exceeds the second highest peak by a 
factor of four. As shown in Fig. 2, it corresponds to the sulfur 
of 6-SH-FAD. The 'observed' C6-S6a bond length was taken 
as the distance between the density maximum of the differ- 
ence-Fourier map and the position of the C6 atom after the 
refinement. In this way, the observed bond length becomes 
largely independent of the respective bond length used in the 
refinement. The observed C6-S6a bond length was 0.16 nm, 
which is slightly, but not significantly, shorter than a double 
bond (0.17 nm) and a single bond (0.18 nm) [29]. 
Since the pK value of 6-SH-FAD is lower than 5.0 when 
bound to glutathione reductase [l 11, the FAD analogue should 
be present in its anionic state with deprotonated S6a. Presum- 
ably, the negative charge at S6a is partially delocalized into 
the flavin-ring system, where it is most likely concentrated 
around N1 and 02a  and stabilized by the helix of amino acid 
residues 339 - 354. This is consistent with the observed C6- 
S6a bond being on the shorter side. 
The difference-Fourier map in Fig. 2 shows only smallish 
densities apart from the added S6a. These are at Gly62 and 
at the redox active disulfide bridge Cys58 - Cys63. Using the 
refined coordinates, these difference densities can be trans- 
lated into shifts. Accordingly, the new substituent S6a has 
increased the distance between Gly62 and the isoalloxazine by 
0.03 nm, and it has caused the disulfide to move by 0.02 nm in 
a direction parallel to the isoalloxazine plane. The coordinates 
indicate further that the salt bridge Lys66-NZ - Glu201-OE2 
is shifted by about 0.01 nm toward the C6 atom, which is well 
within the limits of error and therefore not significant. The 
resulting distances S6a.. .NZ, S6a.. .OE2 and NZ.. .OE2 are 
0.30 nm, 0.34 nm and 0.29 nm, respectively. The short dis- 
tance between S6a and NZ points to a hydrogen bond involv- 
ing a thiolate. 
The structure of GR(6-OH-FAD). The highest peak in 
the (F~oH, obS - F,,,, obs) . expia,,,, talc difference-Fourier map 
exceeds the next highest peak by a factor of two. It is caused 
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Fig. 2. Difference-Fourier map of glutathione reductase containing 4-SH-FAD calculated f rom (F6SH.obs - F,,,, obs) . expictnat,calc. For clarity, 
only positive density is given. The contours are drawn at 15% of the electron-density maximum of this map. The model is centered at the S6a 
atom. Part of the FAD analogue together with chain segments around Cys58, Cys63, Lys66 and Glu201 (all labelled) is depicted, as well as 
parts of Tyr197, Ile198 and Arg291 (not labelled); (+) water molecules 
+ .  + + .  9. 
1 
Fig. 3. Difference-Fourier map of glutathione reductase containing 4-OH-FAD calculated f rom (F60H,obs - Fnor,obs) . expia,,a,,calc. For clarity, 
only positive density is given. The contours are drawn at 28% of the electron-density maximum of this map. The model is centered at the 06a 
atom. Part of the FAD analogue together with chain segments around Cys58, Cys63, Lys66 and Glu201 (all labelled) is depicted, as well as 
parts of Tyr197, Ile198 and Arg291 (not labelled); (+) water molecules 
C6F 479 CSF 473 
Fig. 4. Structural differences between glutathione reductase containing 6-OH-FAD (thick lines) and the native enzyme (thin lines). Atom 06a 
is marked by a dot. Depicted is a part of FAD together with residues Cys63, Lys66 and Glu201 
by the additional oxygen 06a  (Fig. 3). In the same manner as 
with 6-SH-FAD, the C6-06a bond length was determined as 
0.12 nm, which corresponds to a double bond and is smaller 
than a single bond [29]. The short C6-06a bond is consistent 
with a deprotonated 06a, the negative charge of which is 
delocalized towards the N1-02a region of the isoalloxazine, 
where it is stabilized by the helix of amino acid residues 339 - 
354 [27]. The deprotonation of 0 6 a  at pH 7.0 of the X-ray 
analysis is in agreement with the measured pK value of 
5.6 f 0.5 for 6-OH-FAD bound to glutathione reductase. 
Other remarkable difference-Fourier peaks are close to 
04a  and C4a of isoalloxazine (Fig. 3). In the refinement one 
of these peaks corresponded to an appreciable shift of 0 4 a  
caused by a tilt of the isoalloxazine by about 5" (Fig. 4). The 
other peak relates to the disulfide bridge which moves together 
with the adjacent isoalloxazine atoms by about 0.03 nm, keep- 
ing the distance constant (Fig. 4). 
The refined coordinates indicate further that the tilt of the 
isoalloxazine has moved the C6 atom by about 0.04nm 
toward the salt bridge Lys66-NZ - Glu201-OE2. The resulting 
distances 0 6  M... NZ, 0 6  a... OE2 and NZ ... OE2 are 0.29 nm, 
0.35 nm and 0.29 nm, respectively, making a partial negative 
charge at 06a  rather likely. Obviously, 0 6 a  forms such a 
strong hydrogen bond to Lys66-NZ that the whole 
137 
1 
Fig. 5.  Difference-Fourier map of glutathione reductase containing 6-NH2-FAD calculated from ( F G N H 2 ,  obs - F,,,, obs)  . expianat, colt. For clarity, 
only positive density is given. The contours are drawn at 30% of the electron-density maximum of this map. The model is centered at the N6a 
atom. Part of the FAD analogue together with chain segments around Cys58, Cys63, Lys66 and Glu201 (all labelled) is depicted, as well as 
parts of Tyr197, Ile198 and Arg291 (not labelled); (+) water molecules 
Fig. 6. Structural dzjjferences between glutathione reductase containing 6-NH2-FAD (thick lines) and the native enzyme (thin lines). Atom N6a 
is marked by a dot. Part of the FAD analogue together with residues Cys63, Lys66 and Glu201 is depicted 
isoalloxazine follows the movement of 06a  and tilts. The 
isoalloxazine tilt must involve an appreciable amount of en- 
ergy because it concerns the most rigid region of the native 
enzyme [4]. 
The structure of GR(6-NH2-FAD).  The highest peak of the 
difference-Fourier map corresponds to the additional nitrogen 
N6a (Fig. 5). Using the method described for 6-SH-FAD, the 
C6-N6a bond length was determined as 0.15 nm, correspond- 
ing to a single rather than a double bond [29]. 
As with GR(6-OH-FAD), other important peaks of the 
difference-Fourier map occur close to 04a  and C4a of 
isoalloxazine (Fig. 5). The refinement revealed that these 
peaks are caused by a tilt of the isoalloxazine by almost lo", 
similar to the tilt observed in GR(6-OH-FAD). Again, there 
is a substantial shift of 04a  related to one of the peaks; and 
again the disulfide bridge follows the adjacent isoalloxazine 
atoms resulting in a longitudinal 0.05 nm movement (Fig. 6). 
As compared with the native enzyme, the C6 atom of 
isoalloxazine is shifted by 0.05 nm toward the salt bridge 
Lys66-Glu201. Moreover, the salt bridge is rearranged. Lys66- 
NZ has moved away from C6, forming the closest contact to 
Clu201-OE1 (0.27 nm) instead of Glu201-OE2. The resulting 
distances N6a.. .NZ, N6a.. .OE2 and NZ.. .OE2 are 0.36 nm, 
0.30 nm and 0.30 nm, respectively. The large isoalloxazine tilt 
in a very rigid region of the native enzyme [4] indicates that 
the N6a.. .OE2 hydrogen bond formed is rather strong. N6a 
makes a further hydrogen bond to the water molecule Sol-89, 
which is shifted by 0.03 nm toward N6a as compared to the 
native enzyme. 
Clearly, the lengths of the distances between the new sub- 
stituent and the salt bridge atoms have reversed. While the 
substituents S6a and 06a  are close to Lys66-NZ and about 
0.05 nm further away from Glu201-OE2, N6a is 0.06 nm 
closer to OE2 than to NZ. This observation is consistent with 
deprotonated S6a and 06a  carrying a partial negative charge 
and therefore attracting the positive partner NZ via a hydro- 
gen at NZ. It also agrees with two hydrogens and presumably 
a partial positive charge at N6a which is repelled by the posi- 
tively charged NZ amino group, but attracted via one of its 
own hydrogens to the carboxylate atom OE2. 
DISCUSSION 
The observed structural changes increase in the order 
The large sulfur of 6-SH-FAD contacts Lys66-NZ at a reason- 
able hydrogen bond distance of 0.3 nm and causes almost no 
change. Only Gly62 and the redoxactive disulfide bridge are 
pushed somewhat away. In GR(6-OH-FAD) and GR(6-NH2- 
FAD) the isoalloxazine tilts and twists (Figs 4 and 6) to form 
hydrogen bonds between the new substituent and the adjacent 
salt bridge Lys66-NZ - Glu201-OE2. Most conspicuously, the 
0 6 a  and N6a atoms contact different partners of the salt 
bridge, N6a causes a salt-bridge rearrangement in comparison 
to the native enzyme. 
All data (i.e. the observed conformational changes, the 
determined bond lengths between C6 and the substituents, the 
protonation state at pH 7.0 of the X-ray analyses as deduced 
from spectroscopically derived pK values) agree with a 
deprotonated thiol in 6-SH-FAD, a deprotonated hydroxyl in 
6-OH-FAD and an amino group in 6-NH2-FAD. For 6-SH- 
GR(6-SH-FAD) < GR(6-OH-FAD) < GR(6-NH2-FAD). 
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FAD and for 6-OH-FAD the pK value drops on binding to 
glutathione reductase, which is consistent with the stabiliza- 
tion of a negatively charged substituent by Lys66-NZ. A 
further contribution derives most likely from a delocalization 
of the negative charge towards N1 and 0 2 a  of the 
isoalloxazine, where it is stabilized by the helix of amino acid 
residues 339 - 354. 
The enzyme activities of all FAD-modified enzymes 
analyzed are appreciably reduced (Table 1). The highest re- 
sidual activity ( 5 % )  is found for GR(6-NH2-FAD), although 
this analogue causes the largest conformational changes. This 
indicates that catalysis is much more affected by changing the 
electronic properties of the isoalloxazine than by polypeptide 
rearrangements. 
This notion is corroborated by the residual 3% enzymatic 
activity of GR(6-SH-FAD) as compared to no activity for 
GR(6-OH-FAD) as given in Table 1. In both cases, the flavin 
redox potential has dropped by the conjugation of electron 
pairs from thiolate or hydroxylate with the isoalloxazine nu- 
cleus. While this conjugation is limited for the large thiolate 
atom, it is much more pronounced for the smaller hydroxylate 
atom giving rise to a redox potential drop of about 100 mV 
[16], which renders the enzyme inactive. Using this argument, 
the largely reduced activity of GR(6-NH2-FAD) points to a 
conjugation between the lone electron pair of N6a and the 
isoalloxazine nucleus causing some decrease of the redox po- 
tential and a partial positive charge at N6a. 
In conclusion, the described analyses of FAD-modified 
enzymes improved our knowledge of the chemical nature of 
the FAD analogues and of their interactions with functional 
groups of the polypeptide. The internal salt bridge Lys66- 
Glu201 is intimately connected with protonation state and 
partial charge of the substituents at C6 of the bound flavin. 
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